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EDITORIAL
FGF-2: Specific activity in kidney?
Floege et al [1] have set out to determine the specific the presence of inhibitors. These include soluble recep-
tors, which result from alternative exon splicing (for ex-role of fibroblast growth factor-2 (FGF-2) in the adult
kidney. This is a difficult task because the FGF family ample, type IIIa receptors) or from proteolysis, and the
inhibitor of FGF signalling, sprouty [4]. Anti-sense RNAcurrently has 19 members (in humans), some of which
share up to 70% of their amino acid sequence, and in might further modulate ligand availability at different
times [5].many assays have similar activities. Thus, unique identi-
fiers are required to define the function of a member of Mechanisms creating specificity for FGF signaling in
the kidney are not established, but there are a numbera large family of growth factors. Several approaches to
finding these identifiers include: describing an activity of suggestions. Different FGFs have been found to target
different components during development: FGF-2 and -7that is not replicated by other family members when
applied in a physiologically relevant manner; identifying are localized to domains contiguous with FGF receptors
that have relative specificity for these molecules. More-a unique site of expression; and locating a dedicated
receptor or unique combination of receptors. Deletion of over, different proteoglycans are found at different sites
factors distinguished in these ways should also produce a in the renal interstitium, suggesting regional control of
detectable change in some process. If the specific charac- FGF signaling [6]. Lastly, a soluble dominant negative
teristics of factors are not yet apparent, as in a compari- receptor that binds a number of FGFs can abolish renal
son of two factors with apparently identical expression development [7]. Since the phenotype of this “compound
patterns and activities, the function of the two factors knockout” is more severe than known single knockouts,
might be suggested by compound deletions. the inhibitor blocks either a unique, unidentified FGF,
Specificity of function in the FGF family is now appar- or it abolishes signaling by FGFs that are simultaneously
ent from these types of studies. The expression patterns or sequentially required in a specific combination. This
of FGFs and their receptors are exquisitely specific, sug- type of specificity, derived from combinatory activities
gesting that particular sets of autocrine and paracrine of similar factors, has been found in other families of
signals are operative. In a striking example (in hair folli- signaling proteins. For example, IL-6 cytokines have
cles), at least four FGFs and all four FGF receptors are identical activities due to shared receptor components.
expressed in contiguous domains, some as little as one Nevertheless, compound deletions suggest that the
or two cell diameters thick [2]. Additional specificity for growth-promoting or inductive activities of individual
FGF signaling is provided by the differential affinity of cytokines are additive [8].
FGF receptors for different family members. This results Less is known about the behavior of FGFs in the adult
from an alternatively spliced third extracellular immuno- kidney. To establish the specific activity of one family
globulin loop (type IIIb or IIIc receptors) and possibly member, Floege et al [1] have examined the expression
also as a result of variations between the first and second pattern of FGF-2 and one of its receptors, flg. Antibodies
immunoglobulin loops. Binding specificity is also pro- against both extracellular and intracellular epitopes of flg
foundly regulated in vivo by additional molecules, spe- were used, permitting detection of full-length receptors
cific heparan sulfate proteoglycans, which act as co-recep- rather than fragments. The data show overlapping or
tors for the FGFs. In the absence of any other change neighboring expression of ligand and receptor, suggest-
in FGF receptor subtypes, changes in heparan sulfates ing autocrine and paracrine signaling in distal tubular
can select between two FGFs and determine which one segments and paracrine signaling in glomeruli and across
signals [3]. This additional determinant of ligand-recep- the arterial wall. Of course, it will be necessary to map
tor interaction creates greater specificity than may be other FGFs and their receptors in order to establish the
evident in binding assays performed in vitro, which have uniqueness of these FGF-2/flg associations. Also, given
shown various mixtures of FGF and FGF receptor inter- that FGF-2 is secreted by a nonclassical pathway [9],
actions. In vivo, FGF signaling may also be delimited by and nuclear localization has been found, it will also be
necessary to establish when FGF-2 is actually secreted
from these sites. The absence of inhibitors of signalingKey words: fibroblast growth factor, basic FRF, fibroblast growth factor
receptor, flg, hypotension, parietal podocyte. at those locations may also be a prerequisite.
However, there are tantalizing data from FGF-2 knock- 1999 by the International Society of Nephrology
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